Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
CC transcript
Acq. announced
REPLIGEN CORP (RGEN) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/20/2021 GN Repligen to Report First Quarter 2021 Financial Results
03/03/2021 GN Repligen Corporation to Present at Barclays Global Healthcare Conference
02/24/2021 GN Repligen Reports Fourth Quarter and Full Year 2020 Financial Results
02/22/2021 GN Repligen Corporation to Present at 10th Annual SVB Leerink Healthcare Conference
02/11/2021 GN Repligen to Report Fourth Quarter and Full Year 2020 Financial Results
02/08/2021 GN Repligen and Navigo Proteins Announce the Launch of an Affinity Resin for the Purification of COVID-19 Vaccines
01/04/2021 GN Repligen Corporation to Present at 39th Annual J.P. Morgan Healthcare Conference
12/10/2020 GN Repligen Corporation Announces Closing of Public Offering of $312.2 Million, Including Full Exercise of Underwriters' Option
12/07/2020 GN Repligen Corporation Prices Public Offering of Shares of Common Stock
12/07/2020 GN Repligen Corporation Announces Proposed Public Offering of Shares of Common Stock
11/05/2020 GN Repligen Reports Third Quarter 2020 Financial Results and Updates Full Year 2020 Financial Guidance
10/27/2020 GN Repligen Corporation Announces Agreement to Acquire Bioprocess Systems Innovator ARTeSYN Biosolutions and Completes Acquisition of Non-Metallic Solutions
10/22/2020 GN Repligen to Report Third Quarter 2020 Financial Results
10/01/2020 GN Repligen and Navigo Proteins Announce Achievement of Key Milestone in Developing an Affinity Resin for the Purification of COVID-19 Vaccines
07/15/2020 GN Repligen to Report Second Quarter 2020 Financial Results
06/29/2020 GN Repligen Announces Agreement to Acquire Engineered Molding Technology
06/15/2020 GN Repligen Appoints Carrie Eglinton Manner to Board of Directors
04/22/2020 GN Repligen to Report First Quarter 2020 Financial Results
02/20/2020 GN Repligen Reports Fourth Quarter and Full Year 2019 Financial Results
01/07/2020 GN Repligen to Present at the 38th Annual J.P. Morgan Healthcare Conference
10/31/2019 GN Repligen Reports Third Quarter 2019 Financial Results and Updates Full Year 2019 Financial Guidance
10/23/2019 GN Repligen to Report Third Quarter 2019 Financial Results
07/19/2019 GN Repligen Corporation Announces Closing of Public Offerings of $138.1 Million of Common Stock and $287.5 Million of 0.375% Convertible Senior Notes due 2024, Including Full Exercise of Underwriters' Options
07/16/2019 GN Repligen Corporation Announces Pricing of Public Offerings of $120 million of Common Stock and $250 million of 0.375% Convertible Senior Notes due 2024
07/15/2019 GN Repligen Corporation Announces Proposed Public Offerings of $100 million of Common Stock and $250 million of Convertible Senior Notes
06/04/2019 GN Repligen to Present at Jefferies 2019 Healthcare Conference
05/09/2019 GN Repligen Reports First Quarter 2019 Financial Results and Updates Full Year 2019 Financial Guidance
05/02/2019 GN Repligen to Report First Quarter 2019 Financial Results
04/30/2019 GN Repligen Corporation Prices Public Offering of Shares of Common Stock
04/29/2019 GN Repligen Corporation Announces Proposed Public Offering of Shares of Common Stock
04/26/2019 GN Repligen Corporation Announces Agreement to Acquire Process Analytics Innovator C Technologies and Reports Preliminary First Quarter 2019 Financial Results
02/15/2019 GN Repligen to Report Fourth Quarter and Full Year 2018 Financial Results
01/23/2019 GN Consolidated Research: 2019 Summary Expectations for Post, Westlake Chemical, Repligen, Weingarten Realty Investors, AptarGroup, and At Home Group — Fundamental Analysis, Key Performance Indications
01/03/2019 GN Repligen to Present at 37th Annual J.P. Morgan Healthcare Conference
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy